Early, Late-Stage, and Metastatic Lung Cancer Treatment Options
Helping Patients Outperform Dismal Lung Cancer Statistics with Powerful Treatment Options
A lung cancer diagnosis should not leave you staring at a bleak future because Envita’s revolutionary treatment
approach
has proved beneficial for patients affected with this leading cancer killer. At Envita Medical Centers, a world-class
integrative center for Personalized Precision Oncology, we treat the root causes of each patient’s lung cancer with a
unique combination of technologically advanced conventional and alternative therapies. In our clinical experience of
over 25 years, our integrative physicians have been able to help even stage 4 lung cancer patients of various types,
who were left with no option in standard healthcare.
Disclaimer: Individual results will vary. Envita makes no guarantees for outcomes. Each patient case is unique. Please
consult your doctor before making any changes to your medical treatment. Not every patient is a candidate for care or
achieves these results. Treatments used in this case may not all be FDA approved for the treatment of this condition.
Only 21.6%
of lung
cancer cases are caught in the early stages, which
means most lung cancer patients are faced with an
advanced, refractory to treatment, and dangerous form of cancer.Source:
https://seer.cancer.gov/statfacts/html/lungb.html
Disclaimer: Individual results will vary. Envita makes no guarantees for outcomes. Each patient case is unique. Please
consult your doctor before making any changes to your medical treatment. Not every patient is a candidate for care or
achieves these results. Treatments used in this case may not all be FDA approved for the treatment of this condition.
How Envita Overcomes Challenges in Standard Lung Cancer Treatment
The lack of effectiveness in standard treatments make lung cancer a challenging and complicated disease to treat,
contributing to these staggering statistics. The standard treatment in most cancer centers and hospitals in the
country,
are based on the NCCN (National Comprehensive Cancer Network) guidelines, which determine a protocol based on the
stage
and type of lung cancer, leaving no room for personalization. However, Envita being a truly integrative clinic, is not
limited by the NCCN guidelines, which enables us to personalize precision-targeted therapies with a higher potential
of
helping you progress towards a cure for lung cancer.
We know the NCCN regimens are not working as well as they should because they do not take into account each
lung cancer
patient's changing genetic information and immune system targets. At Envita, we use this information in real
time with
our advanced precision algorithms, to proactively treat our lung cancer patients and help reduce chances of
metastasis.
Powerful Combination of Conventional and Alternative Treatments
As described by the National Cancer Institute, our integrative medicine approach combines conventional treatment with
complementary and alternative medicine. However, our complementary therapies go way beyond acupuncture, herbal
medicine,
or dietary supplements, to rebuild your immune system and train it to kill lung cancer cells.
Your immune system is the first and last defense against cancer, which is why strengthening it is
crucial to reduce
the
chances of metastasis. When a lung cancer metastasizes, it spreads from the primary site of origin in the lungs to
gradually affect the lymph nodes, liver, bone, brain, or any other part of the body. To curb the chances of disease
growth and spread, we utilize the latest innovations from decades of cancer research in both conventional and
alternative treatments, bringing you the best of both worlds, personalized for your specific mutations.
Personalized Treatment Offers N-of-1 Clinical Trial Level of Care
When it comes to lung cancer, your disease is unique to you because cancer is a mutation of your specific DNA.
The DNA will continue to mutate and change as the disease progresses, causing the cancer to become more resistant to treatment, often leading to metastasis. Personalizing a
treatment plan helps impact each patient's distinct mutations and decreases chances of metastasis, paving the
way to a holistic recovery with minimal side effects from treatment.
Our personalized treatment plan is based on the N-of-1 model, which is a single subject clinical trial. In this model, a
technologically advanced treatment plan is built on you, for you, and directed to you, unlike large sample
clinical trials where the goal is to test the efficacy of certain new treatments.
At Envita, our oncologists build treatments based on your individual cancer expressions, biomarkers, molecular
profiles,
and immunotherapy targets. To establish these treatment options, we must identify treatment targets for your lung
cancer
via extensive state-of-the-art testing, and not rely on generalized information from clinical trials, which determine
NCCN guided protocols.
Envita Medical Centers Medical Team
Physicians with MD, MD(h), and NMD medical
licenses, including certified oncologists, and certified interventional radiologists,
striving to provide the latest cancer innovations
22
Pharmacists specializing in integrative agents
7
Nurses trained in precision treatment delivery
40+
Envita's Unique Treatment Options for Lung Cancer
Our integrative oncology providers have extensive experience treating even complicated and difficult lung cancer
cases.
We use a unique combination of different types of treatments to effectively treat all stages and types of lung
cancers.
In early-stage cases, our unique treatment options can help avoid chances of metastasis, while in late-stage cases it
counters treatment resistance, enabling patients to respond to care. Our lung cancer specialists have treated and
achieved positive responses in patients who were sent to hospice by other well-established cancer centers, as their
conventional treatment options had been exhausted.
At Envita, we go beyond the standard oncology approach to utilize the latest advances in world-class precision
oncology,
including advanced immunotherapy and genetic targeting. All of our custom developed treatment protocols follow a
four-step process designed to strike at the core causes of your disease, while re-activating your immune system to
improve quality of life, increase longevity, and reduce toxicity.
Step 1
Genomic Identification to Custom-Develop a Targeted Therapy Protocol
At Envita Medical Centers we use next-generation genetic testing, as part of our personalized precision oncology
approach, to pinpoint the medications and natural agents best suited for treating your unique form of lung cancer. In
the NCCN guided conventional cancer centers, not everyone gets access to precision oncology at the beginning of care,
which is crucial for building a comprehensive treatment plan.
The handful of patients who get access to precision receive a watered-down version of Envita's detailed Precision
Oncology Lung Cancer Program. Our proprietary genomic identification
analyses many more parameters than standard oncology to
reveal the issues your body may be dealing with that are leading to treatment resistance. By addressing the resistance
to treatment, we can aid in giving your body the greatest chance to respond to therapy. As far as we know, nobody in
the
United States tests and develops treatments the way we do here at Envita Medical Centers.
Envita Precision Algorithm vs. Standard Oncology Precision Testing
Envita Medical Centers
Standard Oncology Precision Testing
RNA Transcriptome Genes
Envita Medical Centers:20,000+
Standard Oncology:Unchecked
SNV/CNV Genes
Envita Medical Centers:452
Standard Oncology:309
Rearrangements/Fusion Genes
Envita Medical Centers:51
Standard Oncology:27
Microsatellite Instability (MSI)
Envita Medical Centers:Checked
Standard Oncology:Checked
Tumor Mutation Burden (TMB)
Envita Medical Centers:Checked
Standard Oncology:Checked
BRCA 1/2
Envita Medical Centers:Checked
Standard Oncology:Checked
Immunohistochemistry
Envita Medical Centers:Checked
Standard Oncology:Unchecked
Chemosensitivity
Envita Medical Centers:Checked
Standard Oncology:Unchecked
Concurrent Liquid Biopsy
Envita Medical Centers:Checked
Standard Oncology:Unchecked
Exosomal miRNA Analysis
Envita Medical Centers:Checked
Standard Oncology:Unchecked
Circulating Tumor Cells Enumeration
Envita Medical Centers:Checked
Standard Oncology:Unchecked
Pharmacogenomics
Envita Medical Centers:Checked
Standard Oncology:Unchecked
Individualized Therapy Recommendation
Envita Medical Centers:Checked
Standard Oncology:Unchecked
Carcinogenic Exposure - Root Causes
Envita Medical Centers:Checked
Standard Oncology:Unchecked
Inflammation Markers
Envita Medical Centers:Checked
Standard Oncology:Unchecked
Metabolic Target Drivers
Envita Medical Centers:Checked
Standard Oncology:Unchecked
*Individual results may vary. Envita
makes no guarantees for outcomes.
Step 2
Advanced Immunotherapy in Sync With Latest Cancer Research
Immunotherapy is a critical piece for effective lung cancer treatment, and we go beyond basic PD1 inhibitors and
cancer
vaccines to potentially improve patient responses. These forms of immunotherapy in cancer are helpful but may not be
enough for patients whose immune systems have been ravaged by the disease. We have published extensively about “Immunotherapy in Cancer
Treatment”, and in our clinical experience, customizing and combining various forms of advanced immunotherapy
boosts your body's
own ability to fight lung cancer.
The body is naturally the best tool for fighting cancer, as our immune system destroys countless numbers of cancer
cells
every day but when it does not function properly, the cancerous cells grow and multiply. By supplementing our
treatments
with immunotherapy, we optimize the benefits of treatment for our patients.
We have the knowledge and experience to promote detoxification and immune restoration at a level that is unrivaled by
most clinics in the country.
Ultra Analytes Liquid Biopsy
Ultra Analytes Liquid Biopsy is deployed to identify targeted immunotherapy options to help get your
immune system working properly again.
Learn more
about
Immunotherapy
Envita's Ultra Analytes Liquid Biopsy analyses the most recent mutations in your cancer cells by examining the
Circulating Tumor Cells (CTCs), free flowing in your blood. CTCs break away from a growing tumor and enter your blood
stream, spreading the disease to different parts of the body. Analyzing these CTCs help to overcome the challenges of
tissue biopsy, which may not reveal the latest mutations if the tissue sample being tested was not extracted recently.
Basing your treatment on the latest mutations is essential to uproot the disease, reducing chances of a future lung
nodule or lung mass growth and cancer spread.
Step 3
Personalized Drug Design for Optimizing Responses to Anti-Cancer Therapies
Our unique approach to cancer care is so advanced that often commercially available drugs are not viable for
our
patient's genetic cancer targets. To bridge this gap, our personalized drug design includes custom-compounded
adjuvants developed in our own in-house pharmacy. In our clinical experience, a combination
of FDA (Food and Drug Administration) approved drugs, repurposed drugs, and custom-compounded adjuvants, is
most
effective in attacking your cancer's specific targets.
Precision Deployment of New Treatments for Improving Survival Rates
At Envita, we focus on many pathways for treating lung cancer to build a comprehensive protocol, which targets your
cancerous cells while minimizing damage to the surrounding healthy cells. We focus on individualized treatment
protocols
that utilize the most modern and cutting-edge medications and treatments, going beyond the scope of standard chemo and
radiation therapy, also called radiotherapy. Our proprietary treatments include genetically targeted low dose
chemotherapy and other interventional radiology procedures, which enhance treatment benefits for patients, while
reducing side effects, such as exhaustion, hair loss, and a weakened immune system.
GTFC™ is used
to
deliver micro doses of genetically determined
chemotherapy drugs, which optimize
benefits while reducing
several side effects of chemotherapy. Standardized chemotherapy methods often trigger devastating side effects which
may
cause more harm than good to the patient, because the maximum therapeutic dose is not genetically determined based on
each patient's specific cancer expressions. We have extensive experience treating resistant and persistent cancers
with
GTFC™, which may be an effective treatment for those with chemotherapy resistant lung cancers.
CIPI™ (Chemo Immuno Precision Injections)
CIPI™ is
a unique form of precision
tumor
embolization designed to treat resistant and aggressive tumors that are fibrous and difficult to penetrate through
traditional intravenous chemotherapy administration methods. It increases the bioavailability of the anti-cancer
drugs,
potentially increasing tumor kill while strengthening your immune system. This interventional radiology procedure was
created to provide advanced treatment options for patients suffering from late-stage and metastasized lung cancer
where
traditional chemotherapy administration or surgery is not a viable option.
Lung cancers are classified into different types and sub types depending upon the kind of cells that make the lung
tumors and their microscopic appearance. Each of these types can progress from stage 1 to stage 4 lung cancer,
metastasizing to various parts of the body, if not treated effectively. They are categorized as:
Small Cell Lung Cancers (SCLC)
This type of lung cancer is mostly associated with cigarette smoking and is known to metastasize rapidly to
various parts of the body. SCLC is further sub-divided into:
Small Cell Carcinoma (Oat Cell Cancer)
Combined Small Cell Carcinoma (which is a mix of small and large cells)
Non-small Cell Lung Cancers (NSCLC)
NSCLC is more common, comprising about 80% of all lung cancers. It is further sub-divided into:
Adenocarcinoma
Squamous Cell Carcinoma
Large Cell Carcinoma
Superior Sulcus Tumors
These tumors are usually a rare type of NSCLC, but sometimes they may be caused due to other diseases like
lymphoma or tuberculosis. Superior Sulcus Tumors generally grow in the upper part of the lung.
Superior Sulcus Tumors
Carcinoids are made up of neuroendocrine cells found in the lung. They usually grow slower than other types
of lung cancer.
Symptoms of Lung Cancer
Persistent coughing for a prolonged period of time
Wheezing
Shortness of breath
Coughing up blood
Unexplained weight loss
Chest pain
Extreme fatigue
If you experience any of the above symptoms, then request for your local physician to perform a chest X-ray or CT
scan
of your chest. A CT scan report may show lung nodules or mass, which should be investigated properly to check whether
they are benign tumors, or cancerous lumps needing urgent treatment.
Lung Cancer in Non-Smokers
When we begin treating lung cancer, we look deeper into your causative factors that may be feeding your lung cancer.
Most patients are not aware that lung cancer develops from other causes beside cigarette smoking, but our published
paper on Cancer and Infectious Causes
highlights
the
role of infections, such as Chlamydia Pneumoniae, triggering your cancer. Apart from underlying infections, we also
look
at environmental and chemical causes, like radiation, asbestos, heavy metals, toxins, and epigenetics to identify and
treat the root cause of your condition, while attacking the existing cancerous cells.
Risk Factors for Lung Cancer
Smoking cigarettes
Exposure to second-hand smoke
Infectious causes, such as Chlamydia Pneumoniae
Exposure to radioactive agents, such as radon
Exposure to asbestos
Excessive air pollution
Previous exposure to radiation therapy of the lungs
At Envita, we combine the best options from both natural and conventional medicine to provide an all-encompassing
approach to treatment. We have been leading the integrative cancer field for the last two decades, with access to a
wider range of treatment options including the newest and best methods from around the world. Our location in
Scottsdale, Arizona, gives us the advantage of implementing the best integrative techniques in the nation. Our
philosophy is to provide the highest quality compassionate care to our patients and help them make meaningful and
life-changing progress in the fight against their disease.
If you or one of your loved one is struggling with lung cancer, please contact our Patient Care Coordinator team
at 1-866-830-4576 and let us help you fight lung cancer. May God bless you on your journey to
healing.
Choose Envita Medical Centers
Our team is ready to help you get your life back! Please enter your contact information and a Patient Care
Expert will contact you shortly. If you would rather speak now, please give us a call at 1-866-830-4576.
